Switch to: References

Add citations

You must login to add citations.
  1. Lessons from Corporate Influence in the Opioid Epidemic: Toward a Norm of Separation.Jonathan H. Marks - 2020 - Journal of Bioethical Inquiry 17 (2):173-189.
    There is overwhelming evidence that the opioid crisis—which has cost hundreds of thousands of lives and trillions of dollars (and counting)—has been created or exacerbated by webs of influence woven by several pharmaceutical companies. These webs involve health professionals, patient advocacy groups, medical professional societies, research universities, teaching hospitals, public health agencies, policymakers, and legislators. Opioid companies built these webs as part of corporate strategies of influence that were designed to expand the opioid market from cancer patients to larger groups (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • Powered by Sunshine: Next Steps for Making Transparency Matter.Susan Chimonas, Nicholas J. DeVito & David J. Rothman - 2017 - American Journal of Bioethics 17 (6):1-2.
    Download  
     
    Export citation  
     
    Bookmark  
  • Shining Light on Conflicts of Interest.Craig Klugman - 2017 - American Journal of Bioethics 17 (6):1-3.
    Download  
     
    Export citation  
     
    Bookmark